CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,409,000 | +59.1% | 2,150,641 | 0.0% | 0.42% | +47.2% |
| Q2 2022 | $9,054,000 | +24.9% | 2,150,641 | 0.0% | 0.28% | +95.9% |
| Q1 2022 | $7,247,000 | -46.5% | 2,150,641 | -50.0% | 0.14% | +39.4% |
| Q4 2021 | $13,548,000 | +92.6% | 4,301,282 | +100.0% | 0.10% | +2.0% |
| Q3 2021 | $7,033,000 | -61.3% | 2,150,641 | -50.0% | 0.10% | -13.6% |
| Q2 2021 | $18,150,000 | +69.1% | 4,301,282 | +100.0% | 0.12% | -13.2% |
| Q1 2021 | $10,731,000 | -60.5% | 2,150,641 | 0.0% | 0.14% | -53.4% |
| Q4 2020 | $27,184,000 | +28.7% | 2,150,641 | 0.0% | 0.29% | -5.2% |
| Q3 2020 | $21,119,000 | -1.3% | 2,150,641 | 0.0% | 0.31% | -11.2% |
| Q2 2020 | $21,398,000 | +9.5% | 2,150,641 | 0.0% | 0.35% | -31.8% |
| Q1 2020 | $19,549,000 | -1.5% | 2,150,641 | 0.0% | 0.51% | +29.2% |
| Q4 2019 | $19,840,000 | +53.8% | 2,150,641 | -2.0% | 0.39% | +13.2% |
| Q3 2019 | $12,904,000 | -51.2% | 2,194,641 | -0.5% | 0.35% | -42.7% |
| Q2 2019 | $26,456,000 | -0.6% | 2,204,641 | 0.0% | 0.61% | -19.2% |
| Q1 2019 | $26,610,000 | +16.6% | 2,204,641 | +17.7% | 0.75% | -13.6% |
| Q4 2018 | $22,823,000 | +5752.1% | 1,873,779 | +8926.8% | 0.87% | +5331.2% |
| Q3 2015 | $390,000 | – | 20,758 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |